Jeff B. Smaill - Concepedia

Author

Jeff B. Smaill

Also Known As

J B Smaill, J. B. SMAILL, J. Smaill, J.B. Smaill, Jeff B. Smaill, Jeff B Smaill, Jeff B. Smaill, Jeff Bruce Smaill, Jeff Smaill, Jeff B. Smaill

156

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Auckland Cancer Society of New Zealand Maurice Wilkins Centre Victoria University of Wellington Jinan University

About

Jeff B. Smaill is an author at University of Auckland specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	1.6K
2	Biochemistry	16	17	1.3K
3	Natural Sciences	13	13	1.2K
4	Engineering	4	4	346
5	Biomolecular Engineering	4	4	284

Jeff B. Smaill

Publications

Citations

H-Index

Page 1

	Year	Citations
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor David W. Fry, Alexander J. Bridges, William A. Denny, Proceedings of the National Academy of Sciences Drug TargetCell GrowthChemical BiologyMedicinal ChemistrySignaling Pathway	1998	417
Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions Jeff B. Smaill, Gordon W. Rewcastle, Joseph A. Loo, Journal of Medicinal Chemistry Combinatorial ChemistryOrganic ChemistryPharmacotherapyDermatologyHeterocycle Chemistry	2000	263
Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[<i>d</i>]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor Jeff B. Smaill, Brian D. Palmer, Gordon W. Rewcastle, Journal of Medicinal Chemistry	1999	178
The Horner-Wadsworth-Emmons Reaction in Natural Products Synthesis: Expedient Construction of Complex (<i>E</i>)-Enones Using Barium Hydroxide Ian Paterson, Kap‐Sun Yeung, Jeff B. Smaill Synlett Cross-coupling ReactionEnantioselective SynthesisNatural Products SynthesisEngineeringNatural Sciences	1993	176
Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed Y. Yosaatmadja, Shevan Silva, James M. Dickson, Journal of Structural Biology Signal TransductionSignaling PathwayG Protein-coupled ReceptorBreakthrough Inhibitor Azd9291Growth Factor Receptor	2015	145
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954 G.A. Prosser, JN Copp, S. P. Syddall, Biochemical Pharmacology BiochemistryReactive Nitrogen SpecieAnti-cancer Prodrug Cb1954Escherichia Coli NitroreductasesMicrobiology	2009	128
TAS‐120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure Maria Kalyukina, Y. Yosaatmadja, Martin Middleditch, ChemMedChem	2019	118
4-Phenylpyrrolo[3,4-<i>c</i>]carbazole-1,3(2<i>H</i>,6<i>H</i>)-dione Inhibitors of the Checkpoint Kinase Wee1. Structure−Activity Relationships for Chromophore Modification and Phenyl Ring Substitution Brian D. Palmer, Andrew M. Thompson, R J Booth, Journal of Medicinal Chemistry	2006	107
Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Jeff B. Smaill, H. D. Hollis Showalter, Hairong Zhou, Journal of Medicinal Chemistry	2000	89
The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents Sean T. Murphy, Heather L. Case, Edmund L. Ellsworth, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryNovel SeriesMedicineNitrile-containing FluoroquinolonesFluorous Synthesis	2007	87

Page 1